France

1,108,130 series

SeriesLocationUnitFrequencyLatestSource
France exports to Brazil · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to Thailand · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to Tunisia · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to Türkiye · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to Egypt · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to United Kingdom · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to USA · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedFranceUSDAnnual2024-01-01CEPII
France exports to Germany · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its derivatives: salts thereofFranceUSDAnnual2024-01-01CEPII
France exports to Spain · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its derivatives: salts thereofFranceUSDAnnual2024-01-01CEPII
France exports to Algeria · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Canada · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Czechia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Denmark · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Finland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Germany · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Greece · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Argentina · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Indonesia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Ireland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Israel · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Italy · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Japan · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Austria · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Rep. of Korea · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Mexico · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Morocco · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Netherlands · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Pakistan · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Peru · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Poland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Portugal · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to India · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Spain · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Sweden · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Switzerland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Brazil · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Tunisia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Türkiye · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Egypt · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to United Kingdom · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to USA · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaFranceUSDAnnual2024-01-01CEPII
France exports to Denmark · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Germany · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Italy · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Japan · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Austria · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Morocco · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Netherlands · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Portugal · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Romania · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Spain · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Switzerland · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Tunisia · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Türkiye · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to United Kingdom · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to USA · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineFranceUSDAnnual2024-01-01CEPII
France exports to Algeria · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Czechia · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Germany · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Greece · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Indonesia · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Ireland · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Italy · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Japan · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Rep. of Korea · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Mexico · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Other Asia, nes · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Morocco · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Portugal · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to India · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Spain · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Switzerland · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Brazil · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Thailand · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Tunisia · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to United Kingdom · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to USA · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)FranceUSDAnnual2024-01-01CEPII
France exports to Canada · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Chile · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Colombia · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Czechia · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Finland · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Germany · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Greece · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Argentina · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Hungary · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Australia · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Indonesia · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Ireland · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Israel · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Italy · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Japan · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Austria · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Rep. of Korea · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Malaysia · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Mexico · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Other Asia, nes · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Morocco · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to Netherlands · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France exports to New Zealand · Heterocyclic compounds: n.e.s. in heading no. 2933FranceUSDAnnual2024-01-01CEPII
France: prices and trade data | Codefact Research Data